Now in its 6th year, the Japan ADNI (J-ADNI) is working to acquire data comparable to that gathered through other WW-ADNI centers. J-ADNI is enrolling volunteers, including individuals with Alzheimer's disease, Mild Cognitive Impairment, and healthy controls, and collecting and conducting its initial analyses. Preliminary results from J-ADNI analyses are similar to the baseline results from NA-ADNI, E-ADNI and AIBL. J-ADNI has announced the continued funding for J-ADNI 2, up to five years, to recruit an additional 350 volunteers. (100 with early MCI, 100 with late MCI, and 150 with Alzheimer's disease).
View more information about Japanese ADNI initiatives.
In 2009, J-ADNI hosted the first WW-ADNI meeting in Sendai, Japan. The meeting brought together biomarker leaders involved in WW-ADNI to discuss its potential to accelerate the identification, standardization, and validation of biomarkers for Alzheimer's disease.
View the agenda and a photo from this meeting.